Showing 121-130 of 1362 results for "".
Oral Disease Modifying Therapy for MS: Important Considerations
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/oral-disease-modifying-therapy-for-ms-important-considerations/30827/The availability of an oral agent for MS may create a therapeutic dilemma for clinicians as they try to determine the role of new therapy in patient care.Update on Treating Sleep Disorders
https://practicalneurology.com/diseases-diagnoses/sleep/update-on-treating-sleep-disorders/30114/New treatments hold promise of increasing efficacy with precision medicine.Monoclonal Antibody Therapy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/monoclonal-antibody-therapy-in-multiple-sclerosi/30209/Finding the forest among the trees with an update on the safety, efficacy, and mechanisms of monoclonal antibodies.Immunopathogenesis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/immunopathogenesis-of-multiple-sclerosis/30127/Disruption of immune tolerance, inflammation, and blood-brain–barrier breach lead to demyelination and axonal injury.Clinic-Based Assessment and Treatment Strategies for Functional Neurologic Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/clinic-based-assessment-and-treatment-strategies-for-functional-neurologic-disorders/32169/Practical strategies can be used in the clinic for management of functional neurologic disorders.Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Vasculitis Presenting as a Hypertensive Crisis With Back Pain
https://practicalneurology.com/diseases-diagnoses/stroke/vasculitis-presenting-as-a-hypertensive-crisis-with-back-pain/30203/Because laboratory and imaging studies may not be sensitive enough to detect central nervous system vasculitis, maintain a low threshold for further evaluation when clinical suspicion is high.Novel Treatments for Alzheimer Disease Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/novel-treatments-for-alzheimer-disease-disorders/31801/A selection of drugs currently in clinical trials organized by Common Alzheimer Disease Research Ontology focused on mechanisms of action.Epilepsy Essentials: Seizure Disorders and Commercial Motor Vehicle Operators
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-seizure-disorders-and-commercial-motor-vehicle-operators/30858/Clinical neurologists should be familiar with regulations regarding commercial drivers' qualifications to drive and the role of third party examiners.Dystonia Treatment: Current Approach and Future Directions
https://practicalneurology.com/diseases-diagnoses/movement-disorders/dystonia-treatment-current-approach-and-future-directions/32168/The management of dystonia requires a multifacted approach designed to alleviate symptoms, improve functional capacity, and enhance overall quality of life.